Information Library
Results for: Clinical and marketing materials - Clinical Monitoring - Europe - Lithuania
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Model-Based Drug Development
Brochure — October 4, 2011
Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns. -
Bypassing Barriers - Refractory Partial Epilepsy
Case Study — February 2, 2011
Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule. -
Diabetes - Therapeutic Focus
Case Study — February 1, 2011
A dose-ranging clinical study to evaluate the safety, efficacy and tolerability of five doses of Drug X compared with placebo in Type II diabetes patients with no prior exposure to anti-diabetic medication. -
Acute Coronary Syndrome - Tailored Solutions
Case Study — February 1, 2011
Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.
Page 1 of 1 (5 results)

